Ling Zeng - Net Worth and Insider Trading

Ling Zeng Net Worth

The estimated net worth of Ling Zeng is at least $123,145 dollars as of 2024-05-24. Ling Zeng is the Chief Legal Officer & Sec'y of Dicerna Pharmaceuticals Inc and owns about 3,222 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $123,145. Details can be seen in Ling Zeng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ling Zeng has not made any transactions after 2021-09-17 and currently still holds the listed stock(s).

Transaction Summary of Ling Zeng

To

Ling Zeng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ling Zeng owns 1 companies in total, including Omega Therapeutics Inc (OMGA) .

Click here to see the complete history of Ling Zeng’s form 4 insider trades.

Insider Ownership Summary of Ling Zeng

Ticker Comapny Transaction Date Type of Owner
OMGA Omega Therapeutics Inc 2022-03-28 See Remarks

Ling Zeng Latest Holdings Summary

Ling Zeng currently owns a total of 1 stock. Ling Zeng owns 3,222 shares of Dicerna Pharmaceuticals Inc (DRNA) as of September 17, 2021, with a value of $123,145.

Latest Holdings of Ling Zeng

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DRNA Dicerna Pharmaceuticals Inc 2021-09-17 3,222 38.22 123,145

Holding Weightings of Ling Zeng


Ling Zeng Form 4 Trading Tracker

According to the SEC Form 4 filings, Ling Zeng has made a total of 1 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 1,334 shares on September 17, 2021, which brought Ling Zeng around $28,641.

Insider Trading History of Ling Zeng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ling Zeng Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ling Zeng Ownership Network

Ownership Network List of Ling Zeng

No Data

Ownership Network Relation of Ling Zeng


Ling Zeng Owned Company Details

What does Omega Therapeutics Inc do?

Who are the key executives at Omega Therapeutics Inc?

Ling Zeng is the See Remarks of Omega Therapeutics Inc. Other key executives at Omega Therapeutics Inc include director & 10 percent owner Richard A Young , 10 percent owner Flagship Pioneering Fund Vii General Partner Llc , and 10 percent owner Flagship Pioneering Fund Vii, L.p. .

Omega Therapeutics Inc (OMGA) Insider Trades Summary

Over the past 18 months, Ling Zeng made no insider transaction in Omega Therapeutics Inc (OMGA). Other recent insider transactions involving Omega Therapeutics Inc (OMGA) include a net sale of 40,000 shares made by Richard A Young , and a net purchase of 3,323,310 shares made by Flagship Pioneering Special Opportunities Fund Ii General Partner Llc .

In summary, during the past 3 months, insiders sold 0 shares of Omega Therapeutics Inc (OMGA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of Omega Therapeutics Inc (OMGA) were sold and 3,323,310 shares were bought by its insiders, resulting in a net purchase of 3,283,310 shares.

Omega Therapeutics Inc (OMGA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Omega Therapeutics Inc Insider Transactions

No Available Data

Ling Zeng Mailing Address

Above is the net worth, insider trading, and ownership report for Ling Zeng. You might contact Ling Zeng via mailing address: C/o Dicerna Pharmaceuticals, Inc., 33 Hayden Avenue, Lexington Ma 02421.

Discussions on Ling Zeng

No discussions yet.